- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Vail Today
By the People, for the People
Trilogy Capital Reduces Crocs Stake by 80%
Institutional investor sells off over 25,000 shares of the footwear company
Apr. 11, 2026 at 10:10am
Got story updates? Submit your updates here. ›
Trilogy Capital's reduction in its Crocs holdings suggests caution about the footwear company's future prospects, even as the brand continues to see strong performance.Vail TodayTrilogy Capital Inc. has decreased its holdings in Crocs, Inc. (NASDAQ:CROX) by 79.8% in the fourth quarter, according to a recent 13F filing with the Securities and Exchange Commission. The institutional investor now owns 6,335 shares of the textile maker's stock, down from 31,385 shares previously.
Why it matters
This reduction in Trilogy Capital's Crocs position suggests the investment firm may be taking a more cautious view on the footwear company's prospects, even as Crocs shares have seen strong performance in recent quarters. Institutional investor activity can provide insights into broader market sentiment around a stock.
The details
According to the 13F filing, Trilogy Capital sold 25,050 shares of Crocs stock during the fourth quarter. The firm's remaining 6,335 shares were worth approximately $542,000 as of the end of the reporting period. A number of other institutional investors and hedge funds have also modified their Crocs holdings in recent quarters, with some increasing their positions while others, like Trilogy Capital, have reduced their exposure.
- Trilogy Capital filed its 13F report for the fourth quarter of 2025 on April 11, 2026.
- The firm's Crocs position was reduced between the third and fourth quarters of 2025.
The players
Trilogy Capital Inc.
An institutional investment firm that has decreased its holdings in Crocs, Inc. by nearly 80% in recent quarters.
Crocs, Inc.
A global footwear company known for its lightweight, proprietary Croslite foam clogs and other casual shoe styles.
The takeaway
Institutional investor activity can provide insights into broader market sentiment around a stock. Trilogy Capital's decision to significantly reduce its Crocs holdings may signal some caution about the footwear company's future performance, even as Crocs has reported strong results recently.
Vail top stories
Vail events
Apr. 11, 2026
Apres At The AMP - Saturday

